Showing results 1 to 20 of 88
next >
| Issue Date | Title | Author(s) |
| Sep-2013 | 5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells | Can, G.; Akpınar, B.; Baran, Yusuf ; Zhivotovsky, B.; Olsson, M. |
| May-2018 | An answer to colon cancer treatment by mesenchymal stem cell originated from adipose tissue | İplik, Elif Sinem; ERtuğrul, Barış; Kozanoğlu, İlknur; Baran, Yusuf |
| 29-Jun-2015 | Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| Feb-2016 | Apoptotic effects of non-edible parts of Punica granatum on human multiple myeloma cells | Kiraz, Yağmur ; Neergheen-Bhujun, Vidushi S.; Rummun, Nawraj; Baran, Yusuf |
| Aug-2014 | Apoptotic effects of quercitrin on DLD-1 colon cancer cell line | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| Jul-2012 | Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells | Can, Geylani; Çakır, Zeynep; Kartal, Melis; Gündüz, Ufuk; Baran, Yusuf |
| Jun-2013 | Autologous rabbit adipose tissue-derived mesenchymal stromal cells for the treatment of bone injuries with distraction osteogenesis | Sunay, Özgür; Can, Geylani; Çakır, Zeynep; Denek, Ziya; Kozanoglu, İlknur; Erbil, Güven; Yılmaz, Mustafa; Baran, Yusuf |
| Mar-2012 | Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells | Başsoy, Esen Yonca; Baran, Yusuf |
| May-2011 | Bioactive sphingolipids in response to chemotherapy: A scope on Leukemias | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| May-2014 | Bioactive, functional and edible film-forming properties of isolated hazelnut (Corylus avellana L.) meal proteins | Aydemir, Levent Yurdaer; Adan Gökbulut, Aysun ; Baran, Yusuf ; Yemenicioğlu, Ahmet |
| Nov-2017 | Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action | Neergheen-Bhujun, Vidushi; Awan, Almas Taj; Baran, Yusuf ; Bunnefeld, Nils; Chan, Kit; Dela Cruz, Thomas Edison; Egamberdieva, Dilfuza; Elsasser, Simon; Johnson, Mari-Vaughn V.; Komai, Shoji; Konevega, Andrey L.; Malone, John H.; Mason, Paul; Nguon, Rothsophal; Piper, Ross; Shrestha, Uttam Babu; Pesic, Milica; Kagansky, Alexander |
| Mar-2023 | Biodiversity: the overlooked source of human health | Linhares, Yuliya; Kaganski, Alexander; Agyare, Christian; Aksan Kurnaz, Işıl; Neergheen, Vidushi; Kolodziejczyk, Bartlomiej; Baran, Yusuf |
| Sep-2008 | Bisphosphonate treatment and radiotherapy in metastatic breast cancer | Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| 2011 | Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells | Avcı, Çığır Biray; Gündüz, Cumhur; Baran, Yusuf ; Şahin, Fahri; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray |
| Nov-2016 | Cell proliferation and cytotoxicity assays | Adan, Aysun ; Kiraz, Yağmur ; Baran, Yusuf |
| May-2013 | Changes in protein profiles of multiple myeloma cells in response to bortezomib | Turan, Taylan; Şanlı Mohamed, Gülşah ; Baran, Yusuf |
| Jun-2010 | Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells | Baran, Yusuf ; Öztekin, Coşkun; Başsoy, Esen Yonca |
| Sep-2014 | Comparative development of knowledge-based bioeconomy in the European Union and Turkey | Çelikkanat Ozan, Didem; Baran, Yusuf |
| Jun-2009 | Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells | Güçlüler, Gözde; Baran, Yusuf |
| Feb-2009 | Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells | Karabulut, B.; Erten, C.; Gül, M. K.; Cengiz, E.; Karaca, B.; Küçükzeybek, Y.; Görümlü, G.; Atmaca, H.; Uzunoğlu, S.; Şanlı, U. A.; Baran, Yusuf ; Uslu, R. |
